Skip to content

Jingwei Lu

Chief Executive Officer at Synlico.

Earliest Form D on file: Feb 2025

Filed Feb 25, 2025

Synlico

Engineered T cell therapies for solid tumors

Biotech, South San Francisco CA

Signed as Chief Executive Officer

$3M

sold of $3M offered

Form D